Table 2.
Measurements | Group | P1 | |
---|---|---|---|
PrT | PRP | ||
VAS_0 | 7.15±1.46 (a) | 7.73±1.42 (a) | 0.169 |
VAS_21 days | 3.96±1.58 (b) | 4.68±1.36 (b) | 0.099 |
VAS_3 months | 2.50±1.76 (c) | 2.55±0.96 (c) | 0.914 |
VAS_6 months | 1.65±1.67 (d) | 1.59±1.22 (d) | 0.894 |
VAS_12 months | 1.30±1.79 (d) | 1.41±1.40 (d) | 0.811 |
P2 | <0.001 | <0.001 |
ANOVA was used for repeated measures. Means with the same letters (in the same column) are not statistically different, P1 – between-subject effect, P2 – within-subject effect. VAS scores of both groups were significantly improved compared to pretreatment values, and there was no significant difference between the groups at the follow-up periods.